The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Synutra International's revenues will contract -9.1% and EPS will decrease -84.6%.
The average estimate for revenue is $77.6 million. On the bottom line, the average EPS estimate is $0.02.
Last quarter, Synutra International reported revenue of $73.2 million. GAAP reported sales were 36% lower than the prior-year quarter's $114.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at -$0.23. GAAP EPS were -$0.23 for Q3 versus $0.18 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 43.0%, 170 basis points better than the prior-year quarter. Operating margin was 0.5%, much worse than the prior-year quarter. Net margin was -18.1%, much worse than the prior-year quarter.
The full year's average estimate for revenue is $270.5 million. The average EPS estimate is -$1.16.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 76 members out of 148 rating the stock outperform, and 72 members rating it underperform. Among 46 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 19 give Synutra International a green thumbs-up, and 27 give it a red thumbs-down.
Looking for alternatives to Synutra International? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Synutra International to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Synutra International, Inc. Shares Pop on Its Big News
This Chinese baby food company could have a lot of growth left following the discontinued one-child policy, which this equity firm will now get to benefit from.
1 Reason Synutra International's Earnings Aren't So Hot
Don't just count the cash, time it.
China Spoils Global Infant Formula Trade
The country charges that foreign producers colluded to raise prices after tainted milk scandals rocked domestic industry.